MAZE
LIVE

Serial Number

98811175

Owner

Maze Therapeutics, Inc.

Attorney

Joyce Liou

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MAZE Trademark

Serial Number: 98811175

MAZE is a trademark filed by Maze Therapeutics, Inc. on October 21, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Maze Therapeutics, Inc. (4 trademarks)

171 Oyster Point Boulevard, Suite 300
San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

Not Registered

Published for Opposition

December 2, 2025

Goods & Services

Pharmaceutical research and development services; research in the field of genetic modifiers and related therapeutics for genetic diseases; research in the field of genetic variations linked to medical diseases or conditions; research in the field of variant functionalization

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for treating genetic diseases and disorders; pharmaceutical preparations for treating lysosomal storage disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system, and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention and treatment of obesity; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; reagents for medical use; genetic testing preparations for medical purposes, namely, medical diagnostic reagents and assays for testing of body fluids; cells for medical or clinical use; medical diagnostic and testing assays, namely, medical diagnostic reagents and assays for testing of body fluids

Diagnostic preparations for scientific or research use other than for medical use; assays and reagents for scientific or medical research use; genetic testing preparations for scientific or medical research use, namely, assays and reagents for use in genetic and biomedical research; cells for scientific or medical research use

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 27, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 30, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 1, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 1, 2025 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2025 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2024 NWOS
NEW APPLICATION ENTERED
Oct 21, 2024 NWAP